CD24 and cholangiocarcinoma: The present study demonstrated that blocking CXCR4 signaling with AMD3100 results in decreased motility and invasion ability in CD24+ and CD24− cells (although to a greater extent in CD24+ cells), indicating that CXCR4 is important in cholangiocarcinoma cell invasiveness.